130 related articles for article (PubMed ID: 27477274)
1. The ID1-CULLIN3 Axis Regulates Intracellular SHH and WNT Signaling in Glioblastoma Stem Cells.
Jin X; Jeon HM; Jin X; Kim EJ; Yin J; Jeon HY; Sohn YW; Oh SY; Kim JK; Kim SH; Jung JE; Kwak S; Tang KF; Xu Y; Rich JN; Kim H
Cell Rep; 2016 Aug; 16(6):1629-1641. PubMed ID: 27477274
[TBL] [Abstract][Full Text] [Related]
2. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc.
Kim EJ; Kim SH; Jin X; Jin X; Kim H
Cell Death Differ; 2017 Apr; 24(4):649-659. PubMed ID: 28060381
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.
Jin X; Jin X; Kim LJY; Dixit D; Jeon HY; Kim EJ; Kim JK; Lee SY; Yin J; Rich JN; Kim H
Clin Cancer Res; 2018 Jan; 24(2):383-394. PubMed ID: 29208670
[No Abstract] [Full Text] [Related]
4. RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway.
Adamo A; Fiore D; De Martino F; Roscigno G; Affinito A; Donnarumma E; Puoti I; Ricci Vitiani L; Pallini R; Quintavalle C; Condorelli G
Oncotarget; 2017 Feb; 8(8):13476-13487. PubMed ID: 28086236
[TBL] [Abstract][Full Text] [Related]
5. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
[TBL] [Abstract][Full Text] [Related]
6. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
[TBL] [Abstract][Full Text] [Related]
7. Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma.
Cook PJ; Thomas R; Kingsley PJ; Shimizu F; Montrose DC; Marnett LJ; Tabar VS; Dannenberg AJ; Benezra R
Neuro Oncol; 2016 Oct; 18(10):1379-89. PubMed ID: 27022132
[TBL] [Abstract][Full Text] [Related]
8. PTK7 regulates Id1 expression in CD44-high glioma cells.
Liu Q; Zhang C; Yuan J; Fu J; Wu M; Su J; Wang X; Yuan X; Jiang W
Neuro Oncol; 2015 Apr; 17(4):505-15. PubMed ID: 25204555
[TBL] [Abstract][Full Text] [Related]
9. USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance.
Lee JK; Chang N; Yoon Y; Yang H; Cho H; Kim E; Shin Y; Kang W; Oh YT; Mun GI; Joo KM; Nam DH; Lee J
Neuro Oncol; 2016 Jan; 18(1):37-47. PubMed ID: 26032834
[TBL] [Abstract][Full Text] [Related]
10. A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype.
Gangoso E; Thirant C; Chneiweiss H; Medina JM; Tabernero A
Cell Death Dis; 2014 Jan; 5(1):e1023. PubMed ID: 24457967
[TBL] [Abstract][Full Text] [Related]
11. PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway.
Shi L; Fei X; Wang Z; You Y
In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1047-55. PubMed ID: 26170223
[TBL] [Abstract][Full Text] [Related]
12. Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma.
Shevchenko V; Arnotskaya N; Zaitsev S; Sharma A; Sharma HS; Bryukhovetskiy A; Pak O; Khotimchenko Y; Bryukhovetskiy I
Int Rev Neurobiol; 2020; 151():185-200. PubMed ID: 32448607
[TBL] [Abstract][Full Text] [Related]
13. ISL1 Promotes Human Glioblastoma-Derived Stem Cells' Self-Renewal by Activation of Sonic Hedgehog/GLI1 Function.
Liu Y; Luan Y; Ma K; Zhang Z; Liu Y; Chen X
Stem Cells Dev; 2022 May; 31(9-10):258-268. PubMed ID: 35403434
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model.
Tanigawa S; Fujita M; Moyama C; Ando S; Ii H; Kojima Y; Fujishita T; Aoki M; Takeuchi H; Yamanaka T; Takahashi Y; Hashimoto N; Nakata S
Cancer Gene Ther; 2021 Dec; 28(12):1339-1352. PubMed ID: 33414520
[TBL] [Abstract][Full Text] [Related]
15. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
Kaur N; Chettiar S; Rathod S; Rath P; Muzumdar D; Shaikh ML; Shiras A
Mol Cell Neurosci; 2013 May; 54():44-57. PubMed ID: 23337036
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
[TBL] [Abstract][Full Text] [Related]
17. ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways.
Guo Q; Guo P; Mao Q; Lan J; Lin Y; Jiang J; Qiu Y
Med Oncol; 2013 Mar; 30(1):325. PubMed ID: 23377983
[TBL] [Abstract][Full Text] [Related]
18. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
19. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950
[TBL] [Abstract][Full Text] [Related]
20. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]